Melanotan II exerts multiple physiological effects mainly associated with its interaction with melanocortin receptors. Its most notable action is stimulating melanogenesis, the process of melanin production in the skin. By binding to MC1R on melanocytes, it activates the production of cyclic adenosine monophosphate (cAMP), which in turn upregulates the expression of tyrosinase, an enzyme crucial for melanin synthesis. This results in increased skin pigmentation, making it popular, albeit controversially, as a tanning agent. Additionally, Melanotan II has been reported to influence sexual behavior by binding to melanocortin 4 receptors (MC4R) in the central nervous system, potentially enhancing libido in both men and women. However, its use is not approved for human consumption in many countries due to significant risks. These include potential side effects such as nausea, vomiting, and the risk of developing skin tumors due to uncontrolled melanocyte proliferation. Moreover, since it is not regulated as a drug in most regions, there are concerns about product purity and dosage consistency, highlighting the need for caution when considering its use.